To: smh who wrote (3973 ) 6/3/2001 6:50:02 PM From: smh Respond to of 52153 More Golden Age: I had considered the following before and passed, but as a great visionary and adversary to Bill, Larry's comments are worthy of addition to the collection. <"Over the next 10 years you'll see the computer industry maturing," he told a news conference. "There will be more benefit in the next 10 years than in the history of computing." He added, the next big thing will be biotechnology. "If I were 21 years old [now] I wouldn't go into computing; I'd go into biotech or genetic engineering,' Ellison says. "The big leverage point is in molecular biology.">sanjose.bcentral.com siliconvalley.com --------------------------------------------------------- Note to Larry; Bill, having failed to achieve world domination through the PC and then letting the internet slip from his control, will not make the same mistake with biotech. So, knock off the nickel and dime stuff and make a real investment in biotech. Otherwise, Bill will best you again. Note to Bill; In view of the advice I have given Larry, here are my suggestions to you. First, send a PM to SI Biofreaks Rick Harmon, Miljenko Zuanic, and Peter Suzman asking them to list the biotechs they would buy if they were you. Second, buy them all (should they overlook INCY, buy it too). Third, do it now! Regards SMH -------------------------------------------------------- ... Sector will emerge as market leader, in near future. ... Message 15436451 By the way, what industry has more growth prospects that biotech. I can’t think of any! Message 15514975 Biotech in the Market for a Cure wired.com New Hot-Money Havens for the Post-Bear Marketthestreet.com It's the Revolution, Baby: Why to Invest in Biotechnology The golden age of biotech is before us. Recent advances in genetics fuel products that will create more value in the 21st century than the Internet. <snip>fool.com . "...golden ERA of biotechnology..." - Kris Jenner, T. Rowe Price Health Services Fund - Wall $treet Week, 4/20/01 <Gates is looking to the future, first in his new role as a philanthropist and then as a technology investor. And that's Bill's last secret: The Bill Gates of biotechnology is going to be Bill Gates. He has for years been selling Microsoft stock—more than $6 billion worth so far—and investing the proceeds in biotechnology and new-media companies. (See page 82 for more on the biotech industry and Gates's involvement in it.) If the 20th century was the century of the computer, the 21st will be the century of biotech. And as probably the single largest biotech investor in the world, Gates expects the new companies he is supporting to kick in and increase his wealth even further. Whatever happens to cure disease, extend life, or just keep hair on our heads, he'll own a piece of it. Some of these companies will fail, of course, but his investments (he calls them a hobby) are so broad that it still doesn't matter. Imagine what a $5 billion investment in the PC industry would have meant at a comparable time in its development. When the age of the PC is past and Microsoft is in decline, these biotech investments will probably keep Gates in his position as the richest man on earth. Then, he'll have to try even harder to give it all away.>worth.com